Torti Frank

CIK 00016478056 companiesLONDON, X0

SEC Profile

Transactions

Companies

Filings

CIK

0001647805

Recent Transactions

45 trades

Exercise/Conversion
Roivant Sciences Ltd.$ROIV
Stock Option (Right to Buy)
2026-02-23−587,390→ 3,026,184 total
Sale
Roivant Sciences Ltd.$ROIV
Common Shares
2026-02-23$27.51/sh−587,390→ 13,736,547 total
Exercise/Conversion
Roivant Sciences Ltd.$ROIV
Common Shares
2026-02-23$3.85/sh+587,390→ 14,323,937 total
Exercise/Conversion
Roivant Sciences Ltd.$ROIV
Stock Option (Right to Buy)
2026-02-20−1,012,610→ 3,613,574 total
Exercise/Conversion
Roivant Sciences Ltd.$ROIV
Common Shares
2026-02-20$3.85/sh+1,012,610→ 14,749,157 total
Sale
Roivant Sciences Ltd.$ROIV
Common Shares
2026-02-20$27.15/sh−1,012,610→ 13,736,547 total
Sale
Roivant Sciences Ltd.$ROIV
Common Shares
2026-02-19$27.42/sh−1,400,000→ 13,736,547 total
Exercise/Conversion
Roivant Sciences Ltd.$ROIV
Common Shares
2026-02-19$3.85/sh+1,400,000→ 15,136,547 total
Exercise/Conversion
Roivant Sciences Ltd.$ROIV
Stock Option (Right to Buy)
2026-02-19−1,400,000→ 4,626,184 total
Award
Roivant Sciences Ltd.$ROIV
Common Shares
2025-07-30+1,836,547→ 1,836,547 total
Award
Roivant Sciences Ltd.$ROIV
Common Shares
2025-07-30+11,900,000→ 13,736,547 total
Award
Immunovant, Inc.$IMVT
Stock Option (right to buy)
2025-04-01+93,599→ 93,599 total
Award
Immunovant, Inc.$IMVT
Common Stock
2025-04-01+199,365→ 835,039 total
Award
Arbutus Biopharma Corp$ABUS
Stock Option (Right to Buy)
2024-05-23+67,000→ 67,000 total
Award
Immunovant, Inc.$IMVT
Stock Option (right to buy)
2024-04-02+50,167→ 50,167 total
Award
Immunovant, Inc.$IMVT
Common Stock
2024-04-02+120,400→ 635,674 total
Award
Arbutus Biopharma Corp$ABUS
Stock Option (Right to Buy)
2023-05-24+55,000→ 55,000 total
Award
Immunovant, Inc.$IMVT
Common Stock
2023-04-12+121,916→ 515,274 total
Award
Immunovant, Inc.$IMVT
Stock Option (right to buy)
2023-04-12+158,292→ 158,292 total
Purchase
Immunovant, Inc.$IMVT
Common Stock
2022-09-29$5.81/sh+20,000→ 393,358 total
Award
Immunovant, Inc.$IMVT
Common Stock
2022-08-17+225,632→ 373,358 total
Award
Immunovant, Inc.$IMVT
Stock Option (right to buy)
2022-08-17+339,296→ 339,296 total
Award
Arbutus Biopharma Corp$ABUS
Stock Option (Right to Buy)
2022-05-25+41,000→ 41,000 total
Award
Immunovant, Inc.$IMVT
Common Stock
2022-01-10+100,126→ 147,726 total
Award
Immunovant, Inc.$IMVT
Stock Option (right to buy)
2022-01-10+329,485→ 554,748 total
Award
Arbutus Biopharma Corp$ABUS
Stock Options
2021-06-03+22,000→ 22,000 total
Award
Sio Gene Therapies Inc.
Stock Option (Right to Buy)
2021-04-15+42,000→ 42,000 total
Award
Immunovant, Inc.$IMVT
Stock Option (right to buy)
2021-03-19+28,900→ 28,900 total
Award
Immunovant, Inc.$IMVT
Common Stock
2021-03-19+19,200→ 47,600 total
Award
Arbutus Biopharma Corp$ABUS
Stock Options
2020-05-28+22,000→ 22,000 total
Award
Immunovant, Inc.$IMVT
Common Stock
2020-05-15+28,400→ 28,400 total
Award
Immunovant, Inc.$IMVT
Stock Option (right to buy)
2020-05-15+42,600→ 42,600 total
Award
Sio Gene Therapies Inc.
Stock Option (Right to Buy)
2020-04-15+17,500→ 17,500 total
Award
Immunovant, Inc.$IMVT
Stock Option (right to buy)
2019-12-18+893→ 893 total
Award
Immunovant, Inc.$IMVT
Stock Option (right to buy)
2019-12-18+137,617→ 137,617 total
Award
Immunovant, Inc.$IMVT
Stock Option (right to buy)
2019-12-18+3,765→ 3,765 total
Award
Immunovant, Inc.$IMVT
Stock Option (right to buy)
2019-12-18+11,488→ 11,488 total
Award
Myovant Sciences Ltd.
Stock Option (Right to Buy)
2019-08-23+58,608→ 58,608 total
Award
Arbutus Biopharma Corp$ABUS
Stock Options
2019-08-17+22,000→ 22,000 total
Award
Urovant Sciences Ltd.
Stock Option (Right to Buy)
2019-07-09+25,000→ 25,000 total
Award
Sio Gene Therapies Inc.
Stock Option ( Right to Buy)
2019-04-15+255,000→ 255,000 total
Award
Arbutus Biopharma Corp$ABUS
Director Share Option (right to buy)
2018-11-26+44,000→ 44,000 total
Award
Urovant Sciences Ltd.
Stock Option (Right to Buy)
2018-11-21+50,000→ 50,000 total
Award
Myovant Sciences Ltd.
Stock Option (Right to Buy)
2018-11-06+45,000→ 45,000 total
Award
Sio Gene Therapies Inc.
Stock Option ( Right to Buy)
2018-10-15+150,000→ 150,000 total

Companies

Recent Filings

Address

C/O ROIVANT SCIENCES LTD. 7TH FLOOR, 50 BROADWAY

LONDON, X0, SW1H 0DB

View on SEC.gov